Journal
BIOMEDICINES
Volume 10, Issue 3, Pages -Publisher
MDPI
DOI: 10.3390/biomedicines10030644
Keywords
glioblastoma; elderly patients; molecular factors; prognostic factors; comprehensive geriatric assessment
Ask authors/readers for more resources
This paper reviews the clinical and molecular characteristics, current therapeutic options, and prognostic factors of elderly patients with GBM. Elderly people with GBM have a poor prognosis and limited response to treatments, which are correlated with age, clinical frailty, poorer tolerability to surgery or adjuvant radio-chemotherapy, and higher occurrence of comorbidities and/or secondary complications.
Glioblastoma (GBM) is the most aggressive primary brain tumour. As GBM incidence is associated with age, elderly people represent a consistent subgroup of patients. Elderly people with GBM show dismal prognosis (about 6 months) and limited response to treatments. Age is a negative prognostic factor, which correlates with clinical frailty, poorer tolerability to surgery or adjuvant radio-chemotherapy, and higher occurrence of comorbidities and/or secondary complications. The aim of this paper is to review the clinical and molecular characteristics, current therapeutic options, and prognostic factors of elderly patients with GBM.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available